Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value:
$341.87M
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Protagonist Therapeutics Inc.2,449,1832,449,1830$94.54M$118.44M34.65%+$23.90M
CVRx, Inc.(CVRX)4,103,4304,103,4300$51.99M$50.18M14.68%-$1.81M
MeiraGTx Holdings plc(MGTX)6,641,0646,641,0640$40.44M$45.03M13.17%+$4.58M
Legend Biotech CorporationADS(LEGN)814,586814,5860$26.51M$27.64M8.08%+$1.13M
Rapport Therapeutics, Inc.(RAPP)2,498,0512,498,0510$44.32M$25.06M7.33%-$19.26M
PROCEPT BioRobotics Corporation(PRCT)357,939357,9390$28.82M$20.85M6.10%-$7.97M
Nanobiotix S.A.ADS(NBTX)5,623,8165,623,8160$16.14M$20.13M5.89%+$3.99M
Contineum Therapeutics, Inc.CL A(CTNM)1,979,1731,979,1730$28.99M$13.81M4.04%-$15.18M
Xencor, Inc.(XNCR)748,062748,0620$17.19M$7.96M2.33%-$9.23M
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,5980$4.65M$3.15M0.92%-$1.50M
Fate Therapeutics, Inc.(FATE)3,379,0643,379,0640$5.58M$2.67M0.78%-$2.91M
Rallybio Corporation(RLYB)3,636,3633,636,3630$3.49M$2.38M0.70%-$1.11M
Neumora Therapeutics, Inc.(NMRA)1,849,4451,849,4450$19.60M$1.85M0.54%-$17.75M
Nano-X Imaging Ltd.
ORD SHS
158,852158,8520$1.14M$793.5K0.23%-$350.3K
Vor Biopharma Inc.(VOR)1,074,6581,074,6580$1.19M$771.1K0.23%-$421.8K
Lyell Immunopharma, Inc.(LYEL)823,317823,3170$526.9K$442.9K0.13%-$84.0K
Standard BioTools Inc.(LAB)311,967311,9670$545.9K$336.9K0.10%-$209.0K
Adicet Bio, Inc.364,472364,4720$350.6K$275.2K0.08%-$75.4K
Tessera Defense and Homeland Security Inc.(HLSQ)96,86696,8660$70.7K$53.8K0.02%-$16.9K
Senseonics Holdings, Inc.(SENS)54,62154,6210$28.6K$35.8K0.01%+$7.2K
Page 1 of 1
JOHNSON & JOHNSON — 13F Holdings — Q1 2025 | TickerTrail